Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
14,318.00    0.00 (0.00%)
Bid:
14,256.00
Ask:
14,262.00
Spread: 6.00 (0.042%)
Market Cap: £222.05b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

LONDON MARKET MIDDAY: Stocks down but eurozone GDP beats forecasts
7 Mar 2025

LONDON MARKET MIDDAY: Stocks down but eurozone GDP beats forecasts

(Alliance News) - Stock prices in London were lower midday on Friday, as investors remain nervous despite the latest pause on certain US tariffs.

AstraZeneca finds Imfinzi improves survival rates for gastric cancers
7 Mar 2025

AstraZeneca finds Imfinzi improves survival rates for gastric cancers

(Alliance News) - AstraZeneca PLC on Friday said its Imfinzi treatment has demonstrated statistically significant results in a trial testing survival ...

AstraZeneca hails trial results for imfinzi on gastric cancer
7 Mar 2025

AstraZeneca hails trial results for imfinzi on gastric cancer

(Sharecast News) - AstraZeneca said its Imfinzi drug when used with chemotherapy had shown "statistically significant and clinically meaningful improv...

AstraZeneca lung cancer therapy Imfinzi recommended for EU approval
3 Mar 2025

AstraZeneca lung cancer therapy Imfinzi recommended for EU approval

(Alliance News) - AstraZeneca PLC on Monday said its lung cancer drug Imfinzi has been recommended for approval in the EU.

LONDON BRIEFING: FTSE 100 up ahead of UK and US PMI readings
3 Mar 2025

LONDON BRIEFING: FTSE 100 up ahead of UK and US PMI readings

(Alliance News) - Stocks were called higher on Monday morning as investors digest news of greater-than-expected acceleration in China's manufacturing ...

AstraZeneca's Imfinzi gets recommended for fresh EU approval
3 Mar 2025

AstraZeneca's Imfinzi gets recommended for fresh EU approval

(Sharecast News) - AstraZeneca announced on Monday that Imfinzi, or durvalumab, has been recommended for approval in the European Union for adults wit...

AstraZeneca, Amgen drug shows positive results in nasal polyps trials
2 Mar 2025

AstraZeneca, Amgen drug shows positive results in nasal polyps trials

(Alliance News) - An asthma drug has shown positive results when used to treat nasal polyps, researchers have said.

AstraZeneca breast cancer therapy wins recommendation for EU approval
28 Feb 2025

AstraZeneca breast cancer therapy wins recommendation for EU approval

(Alliance News) - AstraZeneca PLC on Friday said its breast cancer therapy, Enhertu, which is being developed jointly with Tokyo-based pharmaceutical ...